Allergan, Inc. is a multi-specialty healthcare company. The Company focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter (OTC) products. It discovers, develops and commercializes a range of products for the ophthalmic, neurological, medical dermatology, breast aesthetics and other specialty markets. The Company operates in two segments: specialty pharmaceuticals and medical devices. The specialty pharmaceuticals segment produces products, including ophthalmic products for dry eye, glaucoma and retinal disease; Botox for therapeutic and aesthetic indications; skin care products for acne and OTC skin care products, and urologics products. The medical devices segment produces medical devices. It also offers a soft shunt used in minimally invasive glaucoma surgeries (MIGs), XEN45, which is implanted by ophthalmologists in the anterior chamber of the eye through an invasive procedure with a single-use, pre-loaded injector.